✦ LIBER ✦

Mitoxantrone in the treatment of acute myelogenous leukemia: a review

✍ Scribed by X. Thomas; E. Archimbaud

Publisher: Springer
Year: 1997
Tongue: English
Weight: 250 KB
Volume: 39
Category: Article
ISSN: 1269-3286
DOI: 10.1007/s00282-997-0163-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of blastic transformation of c

Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone

✍ Zalmen A. Arlin; Ellin Berman; Suresh Jhanwar; Richard Gams; Ingrid Schoch; Gary 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 213 KB

Mitoxantrone in the treatment of relapse

Mitoxantrone in the treatment of relapsed and refractory acute leukemia

✍ P. Meyer; A. D. Ho; G. Ehninger; I. Mjaaland; E. Heidemann; E. Seither 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 245 KB

Twenty-four patients with acute leukemia or blast crisis (BC) of chronic myelocytic leukemia (CML) in relapse or refractory to standard chemotherapy, were eligible for treatment with mitoxantrone. Mitoxantrone (Novantrone| dihydroxyanthracenedione) was administered in a dose of 8-13 mg/m 2 on five c

Treatment of acute myelogenous leukemia

Treatment of acute myelogenous leukemia with outpatient azacitidine

✍ Nimit Sudan; James M. Rossetti; Richard K. Shadduck; Joan Latsko; John A. Lech; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Incidence of secondary acute myelogenous

Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia

✍ Susan G. Kreissman; Richard D. Gelber; Harvey J. Cohen; Luis A. Clavell; Pearl L 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Progress in the treatment of childhood a

Progress in the treatment of childhood acute leukemia: A review

✍ Steinhorn, Sandra C. ;Myers, Max H. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 784 KB

## Abstract The dramatic improvements in the survival experience for children diagnosed with acute leukemia are analyzed using data collected through hospitals participating in the National Cancer Institute's End Results Group Program between 1950 and 1973. Children under 15 years of age who were d

A phase II study of mitoxantrone in acut

A phase II study of mitoxantrone in acute leukemia

✍ Tohru Masaoka; Hirotoshi Shibata; Shigeru Oguma; Kiyoyasu Nagai; Teruo Kitani; A 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 297 KB

A phase 1I study of mitoxantrone (Novantrone| dihydroxyanthracenedione) was conducted in 3.5 patients (22 male: 13 female) with acute leukemia. There were 35 cvaluable cases with a mean age of 34 (range 8-61). Twenty-eight patients had acute non-lymphocytic leukemia (ANLL) and seven had acute lympho